Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
176
datasets available to search
ShareScore release 0.9.0
Dataset results
176 results for “abemaciclib”
Expanded Access Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer
ClinicalTrials.gov study NCT02792725. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Stereotactic Radiosurgery With Abemaciclib, Ribociclib, or Palbociclib in Treating Patients With Hormone Receptor Positive Breast Cancer With Brain Metastases
ClinicalTrials.gov study NCT04585724. IPD Sharing: Not stated. Countries: 0. Publications: 0.
LA-CB1, a novel Abemaciclib derivative induces apoptosis in breast cancer cells by inhibiting the CDK4/6-Cyclin D-Rb-E2F pathway path
GEO Series GSE276256. Homo sapiens. 4 samples. Type: Expression profiling by high throughput sequencing.
Enhancer connectome analysis of human breast cancer cell lines treated with abemaciclib
GEO Series GSE157381. Homo sapiens. 4 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
RNA-seq analysis of human breast cancer cell lines treated with abemaciclib
GEO Series GSE157383. Homo sapiens. 22 samples. Type: Expression profiling by high throughput sequencing.
RNA-seq analysis of MCF7 cells treated with abemaciclib, SR11302
GEO Series GSE157214. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
RNA-seq of detecting the effect of CDK4&6 inhibitor Abemaciclib and VSV-M51 in glioma
GEO Series GSE166914. Homo sapiens. 9 samples. Type: Expression profiling by high throughput sequencing.
FiTAc-seq analysis of PDX 14-07 and MMTV-rtTA/tetO/Her2 tumors treated with abemaciclib
GEO Series GSE157384. Homo sapiens. 8 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
JunB ChIP-seq analysis of MCF7 cells treated with abemaciclib
GEO Series GSE157218. Homo sapiens. 2 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
ATAC-seq analysis of human breast cancer cell lines treated with abemaciclib
GEO Series GSE157082. Homo sapiens. 32 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
H3K27ac ChIP-seq analysis of human breast cancer cell lines treated with abemaciclib, fulvestrant
GEO Series GSE157222. Homo sapiens. 8 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
H3K9me3 ChIP-seq analysis of human breast cancer cell lines treated with abemaciclib
GEO Series GSE157097. Homo sapiens. 8 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
Fra2 ChIP-seq analysis of MCF7 cells treated with abemaciclib
GEO Series GSE157216. Homo sapiens. 2 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
Estrogen Receptor ChIP-seq analysis of MCF7 cells treated with abemaciclib
GEO Series GSE157211. Homo sapiens. 2 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
Dataset related to article "Sticking to the Rules: Outcome and Success Rate of Guideline-Based Diarrhea Management in Metastatic Breast Cancer Patients Treated with Abemaciclib"
<p><strong>Abstract</strong></p><p>In clinical trials testing abemaciclib in patients with hormone-receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer, diarrhea is a very common adverse event (occurring in approximately 85% of patients, any grade). Nonetheless, this toxicity leads to abemaciclib discontinuation in a small proportion of patients (approximately 2%) thanks to the use of effective loperamide-based supportive therapy. We aimed to determine whether the incidence of abemaciclib-induced diarrhea in real-world trials was higher than the one reported in clinical trials, where patients are highly selected, and to evaluate the success rate of standard supportive care in this setting. We conducted a retrospective, observational, monocentric study including 39 consecutive patients with HR+/HER2- advanced breast cancer treated with abemaciclib and endocrine therapy at our institution from July 2019 to May 2021. Overall, diarrhea of any grade occurred in 36 patients (92%), of whom 6 (17%) had diarrhea of grade ≥3. In 30 patients (77%), diarrhea was associated with other adverse events, including fatigue (33%), neutropenia (33%), emesis (28%), abdominal pain (20%), and hepatotoxicity (13%). Loperamide-based supportive therapy was administered to 26 patients (72%). Abemaciclib dose was reduced in 12 patients (31%) due to diarrhea, and treatment was permanently discontinued in 4 patients (10%). In 58% of patients (15/26), diarrhea was effectively managed with supportive care and did not require abemaciclib dose reduction and/or discontinuation. In our real-world analysis, we observed a higher incidence of diarrhea related to abemaciclib compared to data from clinical trials, and a higher rate of permanent treatment discontinuation due to gastrointestinal toxicity. Better implementation of guideline-based supportive care could help to manage this toxicity.</p>
c-Jun ChIP-seq analysis of MCF7 cells treated with abemaciclib
GEO Series GSE157385. Homo sapiens. 2 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.